Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Genetics in non-alcoholic fatty liver disease: The role of risk alleles through the lens of immune response

Silvia Sookoian, Carlos J. Pirola

Clin Mol Hepatol. 2023;29(Suppl):S184-S195. Published online December 5, 2022

DOI: https://doi.org/10.3350/cmh.2022.0318

View: 3708 Download: 173 Web of Science: 8 Crossref: 11

Snapshot

Personalized medicine in nonalcoholic fatty liver disease

Carlos J. Pirola, Silvia Sookoian

Clin Mol Hepatol. 2022;28(4):935-938. Published online June 24, 2022

DOI: https://doi.org/10.3350/cmh.2022.0175

View: 3774 Download: 137 Web of Science: 4 Crossref: 4

Original Article

Loss-of-function HSD17B13 variants, non-alcoholic steatohepatitis and adverse liver outcomes: Results from a multi-ethnic Asian cohort

Yi-Wen Ting, Amanda Shen-Yee Kong, Shamsul Mohd Zain, Wah-Kheong Chan, Hwa-Li Tan, Zahurin Mohamed, Yuh-Fen Pung, Rosmawati Mohamed

Clin Mol Hepatol. 2021;27(3):486-498. Published online February 23, 2021

DOI: https://doi.org/10.3350/cmh.2020.0162

View: 5637 Download: 253 Web of Science: 20 Crossref: 22

Review

Precision medicine in nonalcoholic fatty liver disease: New therapeutic insights from genetics and systems biology

Silvia Sookoian, Carlos J. Pirola

Clin Mol Hepatol. 2020;26(4):461-475. Published online September 10, 2020

DOI: https://doi.org/10.3350/cmh.2020.0136

View: 8315 Download: 279 Web of Science: 36 Crossref: 37

Discussion on critical points for a tailored therapy to cure hepatitis C virus infection

Nadia Marascio, Angela Quirino, Giorgio Settimo Barreca, Luisa Galati, Chiara Costa, Vincenzo Pisani, Maria Mazzitelli, Giovanni Matera, Maria Carla Liberto, Alfredo Focà, Carlo Torti

Clin Mol Hepatol. 2019;25(1):30-36. Published online January 23, 2019

DOI: https://doi.org/10.3350/cmh.2018.0061

View: 7676 Download: 152 Web of Science: 14 Crossref: 16

Original Article

Genetic polymorphism at codon 10 of the transforming growth factor-β1 gene in patients with alcoholic liver cirrhosis

Jong Joon Lee, Soo Kyung Park, Oh Sang Kwon, In Sik Won, Dong Kyu Kim, Young Kul Jung, Yang Suh Ku, Yun Soo Kim, Duck Joo Choi, Ju Hyun Kim

Clin Mol Hepatol. 2011;17(1):37-43. Published online March 21, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.1.37

View: 6840 Download: 58 Crossref: 4

1

Haplotype analysis at R778L mutation of ATP7B gene in Korean patients with Wilson disease

Hyun Seok Jin , Berm Seok Oh

Clin Mol Hepatol. 2009;15(3):295-298. Published online September 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.3.295

View: 4197 Download: 42

2

Genetic epidemiological study on single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic HBV infection

Yoon Jun Kim , Hyo Suk Lee

Clin Mol Hepatol. 2009;15(1):7-14. Published online March 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.1.7

View: 5403 Download: 40 Crossref: 3

Hepatitis B virus genetic diversity and mutant

Hyung Joon Yim

Clin Mol Hepatol. 2008;14(4):446-464. Published online December 31, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.4.446

View: 6545 Download: 144 Crossref: 9

Wilson Disease: an Update

Jeong Kee Seo

Clin Mol Hepatol. 2006;12(3):333-363. Published online January 1, 2000

View: 6822 Download: 241

3

Association between CCR5 Promoter Polymorphisms and Hepatitis B Virus Infection

Hye-Young Chang Sang Hoon Ahn Do Young Kim Jeon-Soo Shin Yong-Soo Kim Sun Pyo Hong Hyun Jae Chung , Soo-Ok Kim Wang Don Yoo , and Kwang-Hyub Han

Clin Mol Hepatol. 2005;11(2):116-124. Published online January 1, 2000

View: 2683 Download: 20

Effects of Genetic Polymorphisms of Ethanol-Metabolizing Enzymes on Alcohol Drinking Behaviors

Joo Young Kee, M.D., Min Ok Kim, M.D., Il Young You, M.D., Ji Young Chai, M.D., Eui Sil Hong, M.D., Sung Chul An, M.D. Heon Kim, M.D. Seon Mee Park, M.D., Sei Jin Youn, M.D. and Hee Bok Chae, M.D.

Clin Mol Hepatol. 2003;9(2):89-97. Published online January 1, 1970

View: 2826 Download: 38

The Association Between Genetic Polymorphisms of the Ethanol - metabolizing Enzymes and Susceptibility to Alcoholic Liver Cirrhosis

Sook Hyang Jung , Han Chu Lee , Jung Hwan Yoon , Hyo Suk Lee , Chung Yong Kim

Clin Mol Hepatol. 1998;4(1):1-11.

View: 2305 Download: 12

Review

Unmet needs in the post-DAA era: the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication

Chung-Feng Huang, Manar Hijaze Awad, Meital Gal-Tanamy, Ming-Lung Yu

Received March 1, 2024 Accepted April 26, 2024

DOI: https://doi.org/10.3350/cmh.2024.0155 [Accepted]

View: 319 Download: 28

1 |

Viewed By 5914	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5292	MAFLD: How is it different from NAFLD?
Viewed By 4992	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4080	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4068	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Cited By 137	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 104	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 82	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 71	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 66	MAFLD: How is it different from NAFLD?

Search